Stay updated on DONATE Study: Dapagliflozin Safety in T2DM Clinical Trial

Sign up to get notified when there's something new on the DONATE Study: Dapagliflozin Safety in T2DM Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the DONATE Study: Dapagliflozin Safety in T2DM Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-17T22:10:27.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-10T22:08:34.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    The page now renders a 403 Forbidden error page instead of the study details, indicating access to the record is blocked.
    Difference
    16%
    Check dated 2026-09-19T20:54:30.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    The page no longer displays the primary condition 'Type 2 diabetes' and the 'related topics' section including 'MedlinePlus Genetics', reducing explicit disease context and linked resources for the study.
    Difference
    0.1%
    Check dated 2026-09-12T18:39:01.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    Added 'Type 2 diabetes' as a topic tag. Introduced a related topics entry featuring MedlinePlus Genetics to connect the study to genetics resources.
    Difference
    0.1%
    Check dated 2026-09-05T20:45:05.000Z thumbnail image
  7. Check
    54 days ago
    Change Detected
    Summary
    New page revision tag added: Revision: v3.6.6. The 'Type 2 diabetes' descriptor and the related topic 'MedlinePlus Genetics' are removed from the page, changing how the study's condition and topics are presented.
    Difference
    0.1%
    Check dated 2026-08-29T20:18:10.000Z thumbnail image

Stay in the know with updates to DONATE Study: Dapagliflozin Safety in T2DM Clinical Trial

Enter your email address, and we'll notify you when there's something new on the DONATE Study: Dapagliflozin Safety in T2DM Clinical Trial page.